Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anatomy of the Eyeball01:20

Anatomy of the Eyeball

6.0K
The eye is a spherical, hollow structure composed of three tissue layers. The outer layer — the fibrous tunic, comprises the sclera — a white structure — and the cornea, which is transparent. The sclera encompasses some of the ocular surface, most of which is not visible. However, the 'white of the eye' is distinctively visible in humans compared to other species. The cornea, a clear covering at the front of the eye, enables light penetration. The eye's middle...
6.0K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

5.7K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The TEMP-PREVENT trial: a study protocol for a randomized, double-blind, placebo-controlled clinical trial of etidronate for treatment in young adult patients with pseudoxanthoma elasticum.

Trials·2025
Same author

Sustainability practices made easy.

Eye (London, England)·2025
Same author

Letter in Response to Verschuere et al.

The Journal of investigative dermatology·2025
Same author

Intraocular Pressure After Anti-Vascular Endothelial Growth Factor Injection in Eyes With a Mineralized Bruch's Membrane Caused by Pseudoxanthoma Elasticum.

Investigative ophthalmology & visual science·2025
Same author

Accelerating the transition from a linear to a circular healthcare sector: ESCH-R: study design and methodology.

Frontiers in public health·2025
Same author

Remote web-based self-assessment of visual acuity versus ETDRS in patients with macular diseases: a method comparison study.

International journal of retina and vitreous·2025

Related Experiment Video

Updated: Jun 5, 2025

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
07:23

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

2.6K

[Retinal artery and vein occlusions].

Ilon K de Boer1, Redmer van Leeuwen1,2

  • 1UMC Utrecht, afd. Oogheelkunde, Utrecht.

Nederlands Tijdschrift Voor Geneeskunde
|December 11, 2024
PubMed
Summary
This summary is machine-generated.

Retinal artery and vein occlusions cause vision loss, with artery occlusions more severe. Both require multidisciplinary care, including cardiovascular risk management and, for artery occlusions, urgent embolism source identification.

More Related Videos

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

2.1K
Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography
07:23

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography

Published on: March 26, 2020

7.1K

Related Experiment Videos

Last Updated: Jun 5, 2025

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
07:23

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

2.6K
In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

2.1K
Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography
07:23

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography

Published on: March 26, 2020

7.1K

Area of Science:

  • Ophthalmology
  • Vascular Medicine

Background:

  • Retinal artery occlusion (RAO) and retinal vein occlusion (RVO) are leading causes of vision loss.
  • RAO typically results in more severe visual acuity reduction than RVO.
  • RVO is significantly more prevalent than RAO.

Observation:

  • Two patient cases illustrate distinct presentations and management strategies for retinal vascular occlusions.
  • A 71-year-old male with central RAO achieved successful treatment after presenting within three hours.
  • A 37-year-old obese male with central RVO required long-term treatment for persistent macular edema using anti-VEGF injections.

Findings:

  • Prompt intervention is crucial for favorable outcomes in RAO.
  • Effective management of RVO, particularly with persistent macular edema, may involve long-term anti-VEGF therapy.
  • Cardiovascular risk factor management is integral to the multidisciplinary care of both RAO and RVO.

Implications:

  • Early diagnosis and treatment of RAO can preserve vision.
  • Integrated cardiovascular and ophthalmological care improves patient outcomes for retinal vascular occlusions.
  • Understanding the specific etiologies and treatment responses is key for managing these sight-threatening conditions.